Meghan E Yahrling, LPC Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 1050 Kings Hwy, Ste #103, Chery Hill, NJ 08034 Phone: 856-438-8458 Fax: 847-859-5885 |
News Archive
The holidays are an exciting and busy time of year as parents race to finish the shopping, decorating and baking. As the number of days left in the calendar year winds down, be sure to allow plenty of time in that hectic schedule for playing with your child and sharing holiday traditions as a family. Nationwide Children's Hospital reminds parents to keep alert to various holiday dangers.
A fellow in the Breast Health Center at Women & Infants Hospital of Rhode Island was one of 25 nationwide to earn a 2011 Breast Cancer Symposium Merit Award from The Conquer Cancer Foundation of the American Society of Clinical Oncology.
As employers increasingly offer no-cost preventive care as a means of controlling health costs, some people under such plans are being charged for services not deemed preventive by the insurer, the Wall Street Journal reports.
Eisai Inc. announced today that the U.S. Food and Drug Administration (FDA) has granted priority review status to the company's New Drug Application (NDA) for the investigational agent eribulin mesylate ("eribulin," also known as E7389). Eisai is seeking FDA approval for eribulin in the treatment of patients with locally advanced or metastatic breast cancer previously treated with at least two chemotherapy regimens, including an anthracycline and a taxane.
› Verified 3 days ago